BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Zahra Amirghofran, Seyed Amir Jalali, Seyed Vahid Hosseini, Mohammad Vasei, Behnam Sabayan, Abbas Ghaderi. Evaluation of CD44 and CD44v6 in Colorectal Carcinoma Patients: Soluble Forms in Relation to Tumor Tissue Expression and MetastasisJournal of Gastrointestinal Cancer 2008; 39(1-4): 73 doi: 10.1007/s12029-009-9062-2
Andrej Veljković, Goran Stanojević, Branko Branković, Dušica Pavlović, Ivana Stojanović, Tatjana Cvetković, Tatjana Jevtović, Dušan Sokolović, Jelena Bašić, Milena Despotović, Branka Đorđević, Gordana Kocić. PARAMETERS OF OXIDATIVE STRESS IN COLON CANCER TISSUEActa Medica Medianae 2016; 55(3): 32 doi: 10.5633/amm.2016.0305
Olfa Baroudi, Sonia Ben Younes, Amel Mézlini, Yves Jean Bignon, Imen Medimeg, Nancy Uhrhammer, Amel Ben Ammar EL Gaiied, Soufia Chabchoub Ellouz. Status of antioxidant enzyme: glutathione peroxidase and total polyphenol level in plasma of Tunisian patients suffering from colorectal and gastric cancer: interaction with clinical outcomeMedical Oncology 2013; 30(4) doi: 10.1007/s12032-013-0731-4
Zhonghu Li, Kai Chen, Peng Jiang, Xi Zhang, Xiaowu Li, Zhihua Li. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patientsDiagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-79
Ranjeeta Thapa, George D. Wilson. The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in CancerStem Cells International 2016; 2016: 1 doi: 10.1155/2016/2087204
Jong-Min Baek, Quanri Jin, Joe Ensor, Delphine R. Boulbes, Francisco J. Esteva. Serum CD44 levels and overall survival in patients with HER2-positive breast cancerBreast Cancer Research and Treatment 2011; 130(3): 1029 doi: 10.1007/s10549-011-1691-z
B. Shivananda Nayak, Sneha Pinto. Protein thiols and thiobarbituric acid reactive substance status in colon cancer patientsScandinavian Journal of Gastroenterology 2007; 42(7): 848 doi: 10.1080/00365520601137264
Livia Raso-Barnett, Balazs Banky, Tamas Barbai, Peter Becsagh, Jozsef Timar, Erzsebet Raso, Andrzej T. Slominski. Demonstration of a Melanoma-Specific CD44 Alternative Splicing Pattern That Remains Qualitatively Stable, but Shows Quantitative Changes during Tumour ProgressionPLoS ONE 2013; 8(1): e53883 doi: 10.1371/journal.pone.0053883
Pantea Rohani, Farahnaz Noroozinia, Parisa Modarresi, Ata Abbasi. CD44 Standard Isoform; Not a Good Marker for Colon CancerInternational Journal of Cancer Management 2017; 10(9) doi: 10.5812/ijcm.9166